Navigation Links
Access Pharmaceuticals to Present New Data on ProLindac(TM) at the AACR Annual Meeting 2008 Conference
Date:4/10/2008

DALLAS, April 10 /PRNewswire-FirstCall/ -- ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP) announced today that its collaborators at prestigious institutes in France and Italy will be presenting new preclinical data on its lead anticancer compound, ProLindac(TM), at the American Association for Cancer Research (AACR) Annual Meeting 2008 taking place April 12-16, 2008 at the San Diego Convention Center. The poster presentation entitled "Characterization of predictive markers and target genes of ProLindac, a novel DACH-platinum compound, compared to oxaliplatin and cisplatin in human cancer cell lines" will be presented on Monday April 14 from 1:00pm to 5:00pm in the "Novel Targets and Mechanisms 2" session held in Exhibit Hall B-F.

ProLindac is Access' novel DACH platinum prodrug which has been shown to be active in a wide variety of solid tumors in both preclinical models and in human trials. Access believes that ProLindac's unique molecular design potentially could eliminate some of the toxic side effects seen in the currently marketed DACH platinum, Eloxatin(TM) or oxaliplatin, which has sales in excess of $2 billion.

"We are grateful for the work and data our European collaborators are presenting at this prestigious meeting next week," stated Jeffrey B. Davis, Access' President & CEO. "As we continue to collect clinical and preclinical data on ProLindac, we are increasingly encouraged and excited about the potential of ProLindac to become a very important tool in the fight against cancer. In the ongoing recurrent ovarian trial, ProLindac continues to show significant DACH platinum anti-cancer activity, with significant reductions in CA-125 biomarkers and anti-tumor activity. We are seeing responses which suggest that ProLindac could be more active as a monotherapy in this patient population than was previously reported for carboplatin and oxaliplatin. Importantly, the side effect profile continues to be quite benign in comparison to o
'/>"/>

SOURCE Access Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. New Legislation Would Expedite Medicare Patient Access to Physical Therapy
2. SurgiQuest Announces First Procedure Using AirSeal(TM) Access System
3. Medicare Advantage Plans Have New, Better Way to Access CMS Data
4. Stryker to Provide Webcast and Telephone Access to Annual Shareholder Meeting
5. Increasing access to antiretroviral drugs would drastically cut AIDS deaths in South Africa
6. Open Biosystems Open Access RNAi Program Continues to Gain Momentum Worldwide
7. Toms of Maine Helps Increase Access to Dental Care
8. Medicare Bidding Program for Durable Medical Equipment May Harm Small Businesses and Decrease Patient Access to Care, Say 137 Members of Congress
9. Cardinal Health, GE Healthcare Broaden Relationship to Offer Greater Access to Myoview(TM) Imaging Agent
10. Governor Rendell Says Pennsylvania is One Step Closer to Providing Access to Health Care for Pennsylvanias Uninsured
11. Country Music Star Troy Gentry Partners With National Non-Profit Patient Advocate Foundation to Spread the Message About Challenges to Healthcare Access for Insured and Uninsured Americans

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)... Evaluation and treatment clinics to resume Monday...cus) November 25, 2009 -- Centegra Health System i... vaccine shots at four Centegra Primary Care (CPC)...cine has arrived. The clinics are at CPC sites in ...ill be open as follows: ,   From 4:30 ...
(Date:11/25/2009)...C sees few signs of trouble with the H1N1 vaccine,...) -- The ongoing H1N1 swine flu pandemic may be dr... younger patients, a U.S. health official said Wed... pneumococcal infections around the country," Dr. ... Immunization and Respiratory Diseases at the U.S....
(Date:11/25/2009)...ntShownforthe4thStraightYear ,, WASHINGTON,No...iance-Georgia(LCA-GA)issuedthe 4thAnnualReportCard...ingmadeagainstthislethaldiseaseinthestateofGeorgia...nationalorganizationdedicatedexclusivelytopatients...gcancer. ,, (Logo: http://www.newscom.com/cgi-b...
(Date:11/25/2009)...oblems that can occur in children with autism and ... plan that includes medication combined with a str... Yale University researchers and their colleagues.... Journal of the American Academy of Child and Adol... National Institute of Mental Health (NIMH) Resear...
(Date:11/25/2009)... Nationwide Imaging Services, known as one of the ...stic imaging equipment, now offering a total solut...options, service and installation with acquisition...logies of California) , B...maging Services is proud to announce its acquisiti...
Breaking Medicine News(10 mins):Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4Health News:Swine Flu Tied to Rise in Pneumonias Among Young 2Health News:Swine Flu Tied to Rise in Pneumonias Among Young 3Health News:Swine Flu Tied to Rise in Pneumonias Among Young 4Health News:Lung Cancer Alliance-Georgia Issues 4th Annual State-Specific Report Card on Lung Cancer 2Health News:Parent training key to improved treatment of behavior problems in children with autism 2Health News:Nationwide Imaging Services, Inc., Leader In Diagnostic Imaging Equipment, Announces Acquisition Of Kosmic Medical, Inc. (dba Atlas Medical Technologies of California) 2Health News:Nationwide Imaging Services, Inc., Leader In Diagnostic Imaging Equipment, Announces Acquisition Of Kosmic Medical, Inc. (dba Atlas Medical Technologies of California) 3
...oost type 2 diabetes risk but could suggest its c...-- Researchers who,ve identified a gene that regul... of type 2 diabetes say their finding may help imp...e gene variants that are important in day-to-day r...
...Nature,s Cure has finalized an,endorsement agreeme...coach,fashion show producer and image consultant. ... his clients, approached Nature,s Cure due to his,...s,and media interviews. Additionally, Nature,s Cur...
... by Professor Makoto Tominaga and Research Assista... Physiological Sciences, Okazaki, Japan) found tha...plex, could be activated by acid stimulus but open...ing in an international journal, EMBO reports, on ...
... As part of its,ongoing efforts to alleviate huma...n, Life for Relief and Development (LIFE), recentl...ly needed medical supplies to Somalia., In partne...wo American non-governmental humanitarian,organiza...
...neficiaries Needing Rehabilitation Services,the Mo...,to go before the current exceptions process for c...ps expires, a majority of the U.S. House of,Repres...f 2007 (HR 748) has,reached 225 cosponsors. The bi...
...e Over 500 Jobs, Expand Health Care Options,for Ar... need for,more site preparation funding and a bett...hen a top Department of Community and Economic,Dev...one we,re,celebrating might never have happened," ...
Other Medicine News:Health News:Scientists ID Gene Regulating Blood Glucose Levels 2Health News:Nature's Cure Acne Products Land Coveted Expert Endorsement of Michael Maddox 2Health News:Majority of U.S. House Supports Repeal of Medicare Therapy Caps 2Health News:DCED Official Helps to Break Ground for Hospital Expansion Project in Southwest PA 2
(Date:11/25/2009)...PRNewswire/--Reportlinker.comannouncesthatanewmark...UnitedStatesDentalDevicesMarketAnalysisandForecast...33/United-States-Dental-Devices-Market-Analysis-an...DevicesMarketAnalysisandForecaststo2015 ,, Sum...thinformationanddatarelatingtotheUSdentaldevicesma...
(Date:11/25/2009).../PRNewswire-FirstCall/--NuVasive,Inc.(Nasdaq: NUVA...sforminimallydisruptivesurgicaltreatmentsforthespi...nday,November30,2009,at5:30p.m.ET/2:30p.m.PT.Theco...bursementfortheCompany,sproductsandwillincludecomm...rsession.Thedial-innumbersare1-877-407-4018fordome...
(Date:11/25/2009)....andSYDNEY,Nov.25/PRNewswire-FirstCall/--HeartWare...innovatorandprovideroflessinvasive,miniaturizedcir...mentofadvancedheartfailure,todayannouncedthatitiss...lPiperJaffrayHealthCareConferenceat8:00amESTonWedn...NewYorkPalaceHotel,December1-2. ,, Alivewebcast...
Breaking Medicine Technology:Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 3Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 4Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 5Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 6Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 7Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 8Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 9Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 10Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 11Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 12NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3Preimplantation genetic diagnosis may pose neurological risks 9300 1Preimplantation genetic diagnosis may pose neurological risks 9300 2Energy and Commerce Committee Advances Long Term Services and Supports in Health Care Reform 52293 1Energy and Commerce Committee Advances Long Term Services and Supports in Health Care Reform 52293 2The National Alliance for Caregiving and MetLife Foundation Honor Innovators Making a Difference in the Lives of Caregivers 52289 1The National Alliance for Caregiving and MetLife Foundation Honor Innovators Making a Difference in the Lives of Caregivers 52289 2The National Alliance for Caregiving and MetLife Foundation Honor Innovators Making a Difference in the Lives of Caregivers 52289 3The National Alliance for Caregiving and MetLife Foundation Honor Innovators Making a Difference in the Lives of Caregivers 52289 4The National Alliance for Caregiving and MetLife Foundation Honor Innovators Making a Difference in the Lives of Caregivers 52289 5
...Sangart, Inc., a privately held,biopharmaceutical ...ommercialization of oxygen transport agents, today...ing board (DSMB) has recommended the,continuation ...d blood,substitute product, Hemospan(R), under cur...the DSMB,s review of the blinded data,from the fir...
...lysis of MA-17 trial data provides evidence for, ...years after finishing ...ibitor class with data demonstrating this potenti...cology, - Half of all breast cancer recurrences ... diagnosis, - Separate analysis publish...
Other Medicine Technology:Independent Data Safety Monitoring Board Recommends Continuation of Sangart's Pivotal Phase III Trials of Hemospan(R) Following Second Interim Review 2VIDEO: Femara(R) helps protect against return of breast cancer even when treatment starts several years after completing tamoxifen therapy 2VIDEO: Femara(R) helps protect against return of breast cancer even when treatment starts several years after completing tamoxifen therapy 3VIDEO: Femara(R) helps protect against return of breast cancer even when treatment starts several years after completing tamoxifen therapy 4VIDEO: Femara(R) helps protect against return of breast cancer even when treatment starts several years after completing tamoxifen therapy 5VIDEO: Femara(R) helps protect against return of breast cancer even when treatment starts several years after completing tamoxifen therapy 6VIDEO: Femara(R) helps protect against return of breast cancer even when treatment starts several years after completing tamoxifen therapy 7
...tics is a leading provider of immunofluorescence a...t includes kits for autoimmune diseases, infectiou...gates and components. Our Impact IFA Test Systems ...izes to choose from. Kit components include substr...
...tics is a leading provider of immunofluorescence a...t includes kits for autoimmune diseases, infectiou...gates and components. Our Impact IFA Test Systems ...izes to choose from. Kit components include substr...
...tics is a leading provider of immunofluorescence a...t includes kits for autoimmune diseases, infectiou...gates and components. Our Impact IFA Test Systems ...izes to choose from. Kit components include substr...
...A products make us a leader in this field. With st... the busy laboratory, our Infectious Disease ELISA...-run consistency. Our Infectious Disease ELISA men...nge of serological assays including ToRCH, EBV, H....
Medicine Products: